New treatment modalities in depression in regards to the use of Ketamine, Psilocybin and Botulinum toxin.

A tétel rövid nézete
dc.contributor.advisorFrecska, Ede
dc.contributor.advisordeptDebreceni Egyetem::Általános Orvostudományi Kar::Pszichiátriai Tanszékhu_HU
dc.contributor.authorPálsson, Móses
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentKósa, Karolina
dc.contributor.opponentMorvai, Szabolcs
dc.contributor.opponentdeptDebreceni Egyetem::Népegészségügyi Kar::Magatartástudományi Intézethu_HU
dc.contributor.opponentdeptKenézy Gyula Kórházhu_HU
dc.date.accessioned2016-05-06T08:52:31Z
dc.date.available2016-05-06T08:52:31Z
dc.date.created2016-03-02
dc.description.abstractThis thesis addresses the antidepressant effect of Ketamine, Botulinum toxin, and Psilocybin on patients suffering from major depressive disorder or depressive symptoms of bipolar disorder. The results are compared to a placebo and then the usual antidepressants. As a conclusion Ketamine can be recommended as an antidepressant when other methods have been unsuccessful. Botulinum toxin can also been recommended when other treatments have failed. But Psilocybin can not be recommended since it has not been studied enough.hu_HU
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent25hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/226632
dc.language.isoenhu_HU
dc.subjectKetaminehu_HU
dc.subjectPsilocybinhu_HU
dc.subjectBotulinum toxinhu_HU
dc.subjectMajor Depressive Disorderhu_HU
dc.subjectAntidepressanthu_HU
dc.subject.dspaceDEENK Témalista::Orvostudományhu_HU
dc.titleNew treatment modalities in depression in regards to the use of Ketamine, Psilocybin and Botulinum toxin.hu_HU
Fájlok
Gyűjtemények
Theses (Faculty of Medicine)